Intent-to-Treat Vs. Non-Intent-to-Treat Analyses Under Treatment Non-Adherence in Mental Health Randomized Trials

Overview

Journal Psychiatr Ann

Specialty Social Sciences

Date 2011 Sep 28

PMID 20717484

Citations 51

Authors

Thomas R Ten Have

Sharon-Lise T Normand

Sue M Marcus

C Hendricks Brown

Philip Lavori

Naihua Duan

Affiliations

Soon will be listed here.

Citing Articles

Accounting for extent of non-compliance when estimating treatment effects on an ordinal outcome in randomized clinical trials.

Zhu J, Li J, Richards A, Chan M, Tai B BMC Med Res Methodol. 2025; 25(1):52.

PMID: 40000941 PMC: 11852586. DOI: 10.1186/s12874-025-02493-6.

Phase-Based Care in Community Mental Health: A Cost-Effective Innovation Using Algorithms, Rating Scales and Treatment Teams for Depression Management.

Rosen J, Hoy M Community Ment Health J. 2024; 60(8):1505-1510.

PMID: 38916775 PMC: 11579101. DOI: 10.1007/s10597-024-01303-5.

Efficacy and safety of long-acting injectable oral antipsychotics in the treatment of patients with early-phase schizophrenia-spectrum disorders: a systematic review and meta-analysis.

Vita G, Tavella A, Ostuzzi G, Tedeschi F, De Prisco M, Segarra R Ther Adv Psychopharmacol. 2024; 14:20451253241257062.

PMID: 38831918 PMC: 11145998. DOI: 10.1177/20451253241257062.

Lifestyle Coaching May Be an Effective Treatment for Schizophrenia.

Kanofsky J, Viswanathan S, Wylie-Rosett J Am J Lifestyle Med. 2024; 18(2):156-161.

PMID: 38559781 PMC: 10979723. DOI: 10.1177/15598276221142307.

Acute and Extended Anxiolytic Effects of Cannabidiol in Cannabis Flower: A Quasi-Experimental Use Study.

Bidwell L, Martin-Willett R, Skrzynski C, Lisano J, Ortiz Torres M, Giordano G Cannabis Cannabinoid Res. 2024; 9(4):1015-1027.

PMID: 38252547 PMC: 11392455. DOI: 10.1089/can.2023.0187.

References

Lewis J, Machin D . Intention to treat--who should use ITT?. Br J Cancer. 1993; 68(4):647-50. PMC: 1968589. DOI: 10.1038/bjc.1993.402. View

Lavori P . Clinical trials in psychiatry: should protocol deviation censor patient data?. Neuropsychopharmacology. 1992; 6(1):39-48; discussion 49-63. View

Dunn G, Bentall R . Modelling treatment-effect heterogeneity in randomized controlled trials of complex interventions (psychological treatments). Stat Med. 2007; 26(26):4719-45. DOI: 10.1002/sim.2891. View

Kraemer H, Wilson G, Fairburn C, Agras W . Mediators and moderators of treatment effects in randomized clinical trials. Arch Gen Psychiatry. 2002; 59(10):877-83. DOI: 10.1001/archpsyc.59.10.877. View

Petkova E, Teresi J . Some statistical issues in the analyses of data from longitudinal studies of elderly chronic care populations. Psychosom Med. 2002; 64(3):531-47. DOI: 10.1097/00006842-200205000-00018. View

Stevens T, Katona C, Manela M, Watkin V, Livingston G . Drug treatment of older people with affective disorders in the community: lessons from an attempted clinical trial. Int J Geriatr Psychiatry. 1999; 14(6):467-72. DOI: 10.1002/(sici)1099-1166(199906)14:6<467::aid-gps956>3.0.co;2-z. View

Sommer A, Zeger S . On estimating efficacy from clinical trials. Stat Med. 1991; 10(1):45-52. DOI: 10.1002/sim.4780100110. View

Horvitz-Lennon M, OMalley A, Frank R, Normand S . Improving traditional intention-to-treat analyses: a new approach. Psychol Med. 2005; 35(7):961-70. DOI: 10.1017/s0033291705004551. View

Prinz R, Smith E, Dumas J, Laughlin J, White D, Barron R . Recruitment and retention of participants in prevention trials involving family-based interventions. Am J Prev Med. 2001; 20(1 Suppl):31-7. DOI: 10.1016/s0749-3797(00)00271-3. View

10.

Katon W, von Korff M, Lin E, Bush T, Ormel J . Adequacy and duration of antidepressant treatment in primary care. Med Care. 1992; 30(1):67-76. DOI: 10.1097/00005650-199201000-00007. View

11.

Schulberg H, Block M, Madonia M, Scott C, Rodriguez E, Imber S . Treating major depression in primary care practice. Eight-month clinical outcomes. Arch Gen Psychiatry. 1996; 53(10):913-9. DOI: 10.1001/archpsyc.1996.01830100061008. View

12.

Hollis S, Campbell F . What is meant by intention to treat analysis? Survey of published randomised controlled trials. BMJ. 1999; 319(7211):670-4. PMC: 28218. DOI: 10.1136/bmj.319.7211.670. View

13.

Heiss G, Wallace R, Anderson G, Aragaki A, Beresford S, Brzyski R . Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin. JAMA. 2008; 299(9):1036-45. DOI: 10.1001/jama.299.9.1036. View

14.

Stein R, Bauman L, Ireys H . Who enrolls in prevention trials? Discordance in perception of risk by professionals and participants. Am J Community Psychol. 1991; 19(4):603-17. DOI: 10.1007/BF00937994. View

15.

Little R, Long Q, Lin X . A comparison of methods for estimating the causal effect of a treatment in randomized clinical trials subject to noncompliance. Biometrics. 2008; 65(2):640-9. DOI: 10.1111/j.1541-0420.2008.01066.x. View

16.

Bellamy S, Lin J, Have T . An introduction to causal modeling in clinical trials. Clin Trials. 2007; 4(1):58-73. DOI: 10.1177/1740774506075549. View

17.

Tenhave T, Coyne J, Salzer M, Katz I . Research to improve the quality of care for depression: alternatives to the simple randomized clinical trial. Gen Hosp Psychiatry. 2003; 25(2):115-23. DOI: 10.1016/s0163-8343(02)00275-x. View

18.

Lewis S, Barnes T, Davies L, Murray R, Dunn G, Hayhurst K . Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia. Schizophr Bull. 2006; 32(4):715-23. PMC: 2632262. DOI: 10.1093/schbul/sbj067. View

19.

OMalley A, Normand S . Likelihood methods for treatment noncompliance and subsequent nonresponse in randomized trials. Biometrics. 2005; 61(2):325-34. DOI: 10.1111/j.1541-0420.2005.040313.x. View

20.

Bao Y, Duan N, Fox S . Is some provider advice on smoking cessation better than no advice? An instrumental variable analysis of the 2001 National Health Interview Survey. Health Serv Res. 2006; 41(6):2114-35. PMC: 1955314. DOI: 10.1111/j.1475-6773.2006.00592.x. View